Weight gain during active tirzepatide treatment is rare but possible if doses are missed frequently, food portions exceed appetite suppression capacity, or underlying metabolic conditions interfere with the medication's effect
Meanwhile, the charity Beat Eating Disorders estimates that 1.25 million people in the UK have an eating disorder
For many, this sustained weight loss can be a game-changer in their weight management journey
Phase 3 Progress and Trial Sites in the UK The UK is playing a central role in the TRIUMPH programme, with several academic centers and primary care research sites actively participating in the trials
Results: We are committed to achieving the best possible results for our clients, having secured thousands of successful outcomes across various practice areas
Visceral Fat Level is a critical parameter that standard scales and BMI calculations cannot measure